CCL2 and acute kidney injury: Serum MCP-1 levels increase in patients with AKI after cardiac surgery and in those with chronic kidney damage [60,71,72], but no study has yet evaluated the serum MCP-1 level as a biomarker of UUTO in a clinical setting.